Adverse effects of biologics: a network meta-analysis and Cochrane overview - Test2 - elhamkhani - TriplyDB

Adverse effects of biologics: a network meta-analysis and Cochrane overview

Adverse effects of biologics: a network meta-analysis and Cochrane overview

http://www.wikidata.org/entity/Q24235218

about

Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome Ayurveda interventions for rheumatoid arthritis Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.Methodology in conducting a systematic review of systematic reviews of healthcare interventions New prospects in the diagnosis and treatment of immune-mediated inner ear disease

P2860

Q24187204-245EB143-F275-482D-A916-3497A31C6AE2 Q24187687-CBC7653B-370E-46D4-83D8-FCD3E7DF2541 Q24203027-03C2617C-F7B2-4CD2-B3B4-3EEA98185095 Q30234672-9A5174D9-778D-492A-930F-CE1BCC3AAD6A Q33811344-D66543B7-70C4-4A00-A781-B802BB4E4083 Q34367600-4E29FC9D-F853-4708-8E75-BD039E0A2902

P2860

Adverse effects of biologics: a network meta-analysis and Cochrane overview

http://www.wikidata.org/entity/Q24235218

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@ast

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@en

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@en-gb

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@nl

type

label

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@ast

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@en

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@en-gb

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@nl

prefLabel

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@ast

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@en

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@en-gb

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@nl

P1433

Q24235218-F0070863-D5DB-4B1C-A967-A89E01837492

P1476

Q24235218-A7F7B042-73D2-4BC4-8A2E-EBCF68BF85AB

P2093

Q24235218-079BF017-967B-47EA-BBAE-7D9ADFC66636

Q24235218-094B6515-1047-47BF-B4CA-FA3ACF36194C

Q24235218-1C8C4CF9-0A37-4077-B687-1612504EEC92

Q24235218-1FEB07E2-326E-40CE-BEDB-62D00A81812D

Q24235218-2F86723C-5227-44DB-A69C-03517F0B98BB

Q24235218-566897D6-7B86-442D-B964-7E51FB935652

Q24235218-611DF02F-2A42-4622-AEC9-CF3B65E1BC82

Q24235218-633EDB07-10D9-4913-93F6-13D460E985B2

Q24235218-DF0C7B2C-73B2-4ACD-AD6A-1352D042006B

P2860

Q24235218-043201A4-9B48-4A4C-9520-7E843CEE9548

Q24235218-065089EF-0DCB-4DFD-A164-70CF52E2A755

Q24235218-154039B2-F713-4DF5-B16D-00C6F95B06FF

Q24235218-179F70AF-35B5-4FBC-B8FE-3978A2077E80

Q24235218-2C929EF7-FF9B-4781-A2CC-B2A756D0258B

Q24235218-2D2CADC1-94A2-41D9-A0E0-A3DDD803048A

Q24235218-30E3250C-4259-4AD7-8C57-B4938EEE3645

Q24235218-3B7187DE-08FA-4BA6-A188-B12BB8DC7D8D

Q24235218-416ECECA-8FB0-481F-8486-4D0914941CAA

Q24235218-4724825A-811F-47BC-A752-4F08B708874E

P31

Q24235218-20B90EA6-9A46-4278-B749-E8113DAD69F7

Q24235218-F1CD83DF-178D-4998-8B0B-6198A0537DF9

P356

Q24235218-261EE88A-55F7-428D-840B-4B39D977B48F

P50

Q24235218-08D4A856-2C6A-4D52-8159-E1F70D7A7752

Q24235218-524F8C2A-0E65-42A1-9A2A-A98F6D281E5D

Q24235218-5866513E-231D-4727-96A4-BF6B743B4BBC

Q24235218-7259C71E-F04C-4FDB-9F35-35941E4A4C62

Q24235218-9E5EB963-2A1E-4FDB-A199-0FC6A52F4BA8

Q24235218-BB35BB7F-7CAD-4F6D-B24C-D343F308DCB4

P577

Q24235218-719B557E-0466-4030-A872-4754EA82E41B

P356

14651858.CD008794

P1433

Cochrane Database of Systematic Reviews

P1476

Adverse effects of biologics: a network meta-analysis and Cochrane overview

@en

P2093

Damian Francis

http://www.w3.org/2001/XMLSchema#string

George A Wells

http://www.w3.org/2001/XMLSchema#string

Jasvinder A Singh

http://www.w3.org/2001/XMLSchema#string

Jochen Schmitt

http://www.w3.org/2001/XMLSchema#string

John K MacDonald

http://www.w3.org/2001/XMLSchema#string

Lara Maxwell

http://www.w3.org/2001/XMLSchema#string

Luciane C Lopes

http://www.w3.org/2001/XMLSchema#string

Michael PT Lunn

http://www.w3.org/2001/XMLSchema#string

Robin Christensen

http://www.w3.org/2001/XMLSchema#string

P2860

Abatacept for rheumatoid arthritis

Interventions for prevention of post-operative recurrence of Crohn's disease

Biologics for rheumatoid arthritis: an overview of Cochrane reviews

TNF-alpha inhibitors for psoriatic arthritis

Rituximab as maintenance therapy for patients with follicular lymphoma

Anakinra for rheumatoid arthritis

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

Adalimumab for treating rheumatoid arthritis

Etanercept for the treatment of rheumatoid arthritis

P31

scholarly article

P356

10.1002/14651858.CD008794

http://www.w3.org/2001/XMLSchema#string

P50

Rachelle Buchbinder

Elizabeth Tanjong Ghogomu

Graziella Filippini

P577

2010-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime